Table 2 Cost effectiveness analysis of IVF/PGD versus natural conception for BRCA negative embryo selection
From: Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis
Strategy | Cost (NIS) | Incremental cost | QALY | Incremental QALY | ICER (NIS) |
|---|---|---|---|---|---|
3% discount rate | |||||
IVF/PGD | 12,057 | Â | 30.1359 | Â | Â |
Natural conception | 30,868 | 18,811 | 30.2611 | 0.1252 | 150,219 |
Not discounted (0% discount rate) | |||||
IVF/PGD | 49,767 | 0 | 77.7 | 0 | Â |
Natural selection | 66,809 | 17,041 | 76.8 | -0.866 | -19,658 |